Press release
Heart Failure POC & LOC Devices Market worth $310.93 million by 2030, growing at a CAGR of 19.59% - Exclusive Report by 360iResearch
Heart Failure POC & LOC Devices Market | 360iResearch
Request Sample Copy of this Report @ https://www.360iresearch.com/library/intelligence/heart-failure-poc-loc-devices?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Market Segmentation & Coverage:
This research report categorizes the Heart Failure POC & LOC Devices Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Test Type, market is studied across Genomic Testing, Metabolomic Testing, and Proteomic Testing. The Genomic Testing is projected to witness significant market share during forecast period.
Based on Technology, market is studied across Array-based Systems and Microfluidics. The Array-based Systems is projected to witness significant market share during forecast period.
Based on End-user, market is studied across Assisted Living Healthcare Facilities, Clinics, Home, Hospitals, and Laboratory. The Clinics is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Heart Failure POC & LOC Devices Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the Heart Failure POC & LOC Devices Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the Heart Failure POC & LOC Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Inc., ACON Laboratories Inc, Amgen Inc., AstraZeneca PLC, Becton, Dickinson & Company, bioMérieux S.A., Boditech Med Inc., Dolphin Corporation, Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche Ltd., Jant Pharmacal Corporation, Medtronic PLC, Novartis AG, Samsung Electronics Co. Ltd., and Sanofi S.A..
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Heart Failure POC & LOC Devices Market, by Test Type
7. Heart Failure POC & LOC Devices Market, by Technology
8. Heart Failure POC & LOC Devices Market, by End-user
9. Americas Heart Failure POC & LOC Devices Market
10. Asia-Pacific Heart Failure POC & LOC Devices Market
11. Europe, Middle East & Africa Heart Failure POC & LOC Devices Market
12. Competitive Landscape
13. Competitive Portfolio
14. Appendix
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Heart Failure POC & LOC Devices Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Heart Failure POC & LOC Devices Market?
3. What is the competitive strategic window for opportunities in the Heart Failure POC & LOC Devices Market?
4. What are the technology trends and regulatory frameworks in the Heart Failure POC & LOC Devices Market?
5. What is the market share of the leading vendors in the Heart Failure POC & LOC Devices Market?
6. What modes and strategic moves are considered suitable for entering the Heart Failure POC & LOC Devices Market?
Read More @ https://www.360iresearch.com/library/intelligence/heart-failure-poc-loc-devices?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Heart Failure POC & LOC Devices Market worth $310.93 million by 2030, growing at a CAGR of 19.59% - Exclusive Report by 360iResearch here
News-ID: 3251561 • Views: …
More Releases from 360iResearch
Embedded Finance Market worth $228.79 billion by 2030, growing at a CAGR of 18.7 …
The "Embedded Finance Market by Services (Embedded Banking Services, Embedded Insurance, Embedded Lending), Integration Type (Application Programming Interfaces, Software Development Kits), Business Model, End-Use - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/embedded-finance
Embedded Finance refers to the integration of financial services, such as lending, insurance, payments, or banking, directly within the products or services of non-financial companies using Application Programming Interfaces (APIs).…
Currency Management Market worth $1,305.97 billion by 2030, growing at a CAGR of …
The "Currency Management Market by Offering (Services, Software), Type (Fixed Currency Exchange, Floating Currency Exchange), End-User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/currency-management
Currency management encompasses strategies, methodologies, and tools employed by firms and financial institutions to address risks and potential benefits associated with currency fluctuations, involving activities such as hedging, arbitrage, and strategic investment planning to mitigate negative financial impacts…
Bromacil Market worth $191.69 million by 2030, growing at a CAGR of 4.56% - Excl …
The "Bromacil Market by Formulation (Granular Formulation, Liquid Formulation), Distribution Channel (Offline, Online) - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/bromacil
Bromacil, a herbicide used to control broadleaf weeds and grasses, is vital for vegetation management in agricultural and non-cropland areas due to its soil-residual activity and efficacy in preventing weed growth, ultimately enhancing agricultural productivity and land utility. Applications span agricultural…
Carbon Monoxide Market worth $7.92 billion by 2030, growing at a CAGR of 4.45% - …
The "Carbon Monoxide Market by Purity Level (98% - 99%, Over 99%), Application (Chemical Synthesis, Food & Beverage, Fuel) - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/carbon-monoxide
The scope of carbon monoxide (CO) market research encompasses comprehensive evaluations of production, distribution, application, and end-use industries, providing insights into current market size, projected growth, and future demand across key regions such as North…
More Releases for Heart
Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr
When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue…
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH…
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot
Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after…
Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape.
Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver…
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape.
Heart failure is also known as congestive heart failure (CHF).…
Congestive Heart Failure (Heart Failure) Market Research Report
Latest industry research report on: Congestive Heart Failure (Heart Failure) Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
GlobalData's clinical trial report, Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an…
